News
My Top Dividend-Paying, Deep-Value Stock to Buy in August
What's better than a stock that pays great dividends? How about one that's also a bargain? Granted, most strong dividend stocks aren't available at a discount in the current high-flying market
Warren Buffett Bought UnitedHealth Stock. Should You Do the Same?
Shares of health insurer UnitedHealth Group (NYSE: UNH) received a boost last week after investors learned that Warren Buffett's company, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), has invested
Why UnitedHealth Stock Dipped Today After Bumping Higher Monday
What the stock analysis community giveth, it can also taketh away.
That was the dynamic behind the slide of UnitedHealth Group (NYSE: UNH) stock on Tuesday. As in the previous trading session, the
If You'd Invested $1,000 in UnitedHealth Group 3 Years Ago, Here's How Much You'd Have Today
UnitedHealth Group (NYSE: UNH) has been a staple in the healthcare world for decades and is one of the largest companies in the world, with a market cap of around $280 billion as of Aug. 18
Is Pfizer's 6.8%-Yielding Dividend Too Good to Be True?
Finding a high-yielding stock that is safe to hang on to can be a rarity. When yields get high (e.g., more than 5%), usually there's a reason behind it. And investors are often hesitant to invest in
Why UnitedHealth Stock Pushed Higher on Monday
UnitedHealth Group (NYSE: UNH), by far the health insurance stock that's gotten most of the market's attention over the past few trading sessions, had a good Monday on the exchange. Its shares added
2 Top Dividend Stocks to Buy on the Dip
Dividend stocks are a great investment choice for many reasons. Buying on the dip is even better, provided, of course, they have the means to bounce back.
Investors looking for companies that fit
After a Strong Quarterly Result, Is It Finally Safe to Buy Pfizer Stock Again?
Pfizer (NYSE: PFE) was a hot stock during the pandemic, but it has been crashing in recent years. The company's COVID vaccine resulted in the business posting record sales and profits in 2022. But
UnitedHealth's Dividend Yield Has Never Been This High. Should You Buy the Stock?
UnitedHealth Group (NYSE: UNH) has been a solid dividend growth stock for years. Generally, its yield has been fairly low, due to the stock's rising value. Even as the healthcare insurance giant has
Why I Bought the Dip in UnitedHealth Group
The market has abandoned UnitedHealth Group (NYSE: UNH), and that's exactly why I'm buying it. While investors flee the stock over rising medical costs and regulatory headlines, they're missing a
Best Stock to Buy: Novo Nordisk Stock vs. UnitedHealth Stock
Novo Nordisk (NYSE: NVO) and UnitedHealth (NYSE: UNH) have seen their share prices fall in recent weeks.
*Stock prices used were the afternoon prices of Aug. 11, 2025. The video was published on
Meet the 3.4% Yield Dividend Stock That Could Soar in 2026
People have sung Fleetwood Mac's lyrics for decades: "Don't stop thinking about tomorrow." But investors might want to focus on a different timeline.
No one knows what tomorrow holds. At least with
Why UnitedHealth Stock Was Climbing on Wednesday
UnitedHealth (NYSE: UNH) stock was proving to be beneficial for investors' financial health on Hump Day. They were trading the big health insurance company's stock up by nearly 4% in late-session
3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer
Many income investors probably have mixed emotions about stocks with ultra-high dividend yields. On one hand, they love the tremendous income these stocks provide. On the other hand, they might
If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have Today
Wondering how well you'd have done if you'd invested in pharmaceutical giant Pfizer (NYSE: PFE) three years ago and hung on? Well, I'm afraid the answer isn't pretty: If you'd investing $1,000 in
Pfizer Just Beat Its Earning Estimates. Is This the Beginning of a Turnaround for the Pharmaceutical Stock?
Pfizer (NYSE: PFE) has been a terrible investment over the past three years. Revenue and earnings have generally moved in the wrong direction, as the company has been unable to follow up on the
Meet the 7.3% Yield Dividend Stock That Could Soar in 2026
It's been a tough stretch for pharmaceutical giant Pfizer (NYSE: PFE). The company enjoyed a vaccine windfall during the COVID-19 pandemic, but revenue and profits cratered as the pandemic eased and
Why Is Everyone Talking About UnitedHealth Group Stock?
UnitedHealth (NYSE: UNH) stock is trading near its 52-week low.
*Stock prices used were the afternoon prices of Aug. 4, 2025. The video was published on Aug. 6, 2025.
Source Fool.c
This 7% Yielding Stock Just Raised Its Profit Forecast. Is It Time to Buy?
Incoming patent cliffs regarding some of Pfizer's (NYSE: PFE) largest revenue streams have been pressuring the pharmaceutical stock. The price is down, but its dividend payout keeps rising. Last
If You'd Invested $1,000 in UnitedHealth Group 3 Years Ago, Here's How Much You'd Have Today
UnitedHealth Group (NYSE: UNH) has been in the news over the past several months, but not positively. Unfortunately, the CEO of its healthcare unit, Brian Thompson, was shot and killed late last
UnitedHealth Stock Investors: You Need to Know This Before Buying or Selling This Stock
UnitedHealth Group (NYSE: UNH) stock investors will want to digest this information before making the important decision to invest in or divest from this stock.
*Stock prices used were the
1 Reason to Buy Pfizer (PFE) Stock
I can actually think of multiple reasons to buy shares of Pfizer (NYSE: PFE) stock, but if I had to focus on only one, I'd choose its dividend. The stock's dividend yield was recently a whopping
Why Shares of Pfizer Soared Today
Shares of the large pharmaceutical company Pfizer (NYSE: PFE) closed up over 5% today after a strong earnings report that included raising its full-year profit outlook for 2025.
In the second
UnitedHealth Group Just Released More Bad News. Should You Avoid the Stock?
Things are going from bad to worse for UnitedHealth Group (NYSE: UNH). Investors were already enduring a tough year in 2025, with the company facing myriad bits of bad news, including poor financial
If You'd Invested $1,000 in PFE 5 Years Ago, Here's How Much You'd Have Today
Five years ago, the world was in the thick of the COVID-19 global pandemic, bringing Pfizer (NYSE: PFE) into the spotlight because of the role it played in developing the COVID-19 vaccine with its


